Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


A Phase 2, Multiple-Dose Study of The Efficacy and Safety of Wafermine™ (Sublingual Ketamine) in Participants Experiencing Acute Post-Operative Bunionectomy or Abdominoplasty Pain


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03246971

Organisation Name: iX Biopharma Ltd.

Overal Status: Completed

Start Date: August 24, 2017

Last Update: July 23, 2018

Lead Sponsor: iX Biopharma Ltd.

Brief Summary: This study evaluates the safety and effectiveness of Wafermine™ for post-bunionectomy or post-abdominoplasty pain over a 24 hours period. For subjects undergoing bunionectomy, 2 out of 3 subjects will receive Wafermine™ and 1 out of 3 subjects will receive placebo. For subjects undergoing abdominoplasty, 3 out of 4 subjects will receive Wafermine™ and 1 out of 4 subjects will receive placebo.

Conditions:
  • Acute Pain
  • Bunion
  • Abdominoplasty


Total execution time in seconds: 0.20121598243713